number of downloads : ?
language
eng
Author
Ono, Takaaki Divison of Hematology, Hamamatsu University School of Medicine, Shizuoka, Japan
Takahashi, Naoto Department of Hematology, Nephrology, and Rheumatology, Akita University School of Medicine, Akita, Japan
Kizaki, Masahiro Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
Kawaguchi, Tatsuya Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
Yamamoto , Kazuhito Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan
Ohnishi, Kazunori Tokai‐Hokuriku Block Blood Center, Seto, Japan
Naoe, Tomoki National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
Matsumura, Itaru Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka‐Sayama, Japan
Subject
chronic myeloid leukemia
comorbidity
dasatinib
imatinib
nilotinib
Journal Title
CANCER SCIENCE
ISSN
1347-9032
ISSN(Online)
1349-7006
Published Date
2020-07-22
DOI
Publisher
WILEY
NII Type
Journal Article
OAI-PMH Set
Faculty of Medicine
Remark
This sub-analysis was performed based on previously published data from the New TARGET observational study 1 (UMIN 00003581) conducted by the JSH. The New TARGET observational study 1 was supported by research funding to JSH from Novartis Pharmaceuticals and Bristol-Myers Squibb. We would like to express our gratitude to all the study participants and their families, and the study investigators at participating study sites. We also thank the New TARGET data center (EPS. Co.).
このエントリーをはてなブックマークに追加